Matthew J Newman (Matthew Newman)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 7

Top Topics

Acute Myeloid Leukemia

Oxide Nanoparticles

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

JCO oncology practice

Pharmacotherapy

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Skoloda, Matthew J Newman, Haval Norman, Jamie E Ziggas, Richard F Ambinder
Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients. JCO oncology practice (2024)
Daniel Skoloda, Matthew J Newman, Haval Norman, Jamie E Ziggas, Richard F Ambinder
Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients. JCO oncology practice 20 (5) (2024)
Matthew J Newman
Recognizing the potential for copper-related toxicities from liposomal daunorubicin--cytarabine. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (3) (2021)
Kyle Zacholski, Bryan Hambley, Erin Hickey, Sarah Kashanian, Andrew Li, Maria R Baer, Vu H Duong, Matthew J Newman, Amy DeZern, Ivana Gojo, B Douglas Smith, Mark J Levis, Ravi Varadhan, Eric Gehrie, Ashkan Emadi, Gabriel Ghiaur
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Valerie Relias, Ali McBride, Matthew J Newman, Shilpa Paul, Seyyedeh Saneeymehri, Genique Stanislaus, Jennifer Tobin, Caroline J Hoang, Joanne C Ryan, Ilene Galinsky
Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (3) (2020)
Carmen F Nobre, Matthew J Newman, Anne DeLisa, Pauline Newman
Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations. Cancer chemotherapy and pharmacology 84 (2) (2019)
Matthew J Newman, Midhun Malla, Ivana Gojo
Azacitidine-Induced Pericarditis: A Case Series. Pharmacotherapy 36 (4) (2016)